Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation.

Publikation

Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation.

Wissenschaftlicher Artikel/Review - 29.11.2021

Polymeris Alexandros A, Macha Kosmas, Paciaroni Maurizio, Wilson Duncan, Koga Masatoshi, Cappellari Manuel, Schaedelin Sabine A, Zietz Annaelle, Peters Nils, Seiffge David Julian, Haupenthal David, Gassmann Luise, De Marchis Gian Marco, Wang Ruihao, Gensicke Henrik, Stoll Svenja, Thilemann Sebastian, Avramiotis Nikolaos S, Bonetti Bruno, Tsivgoulis Georgios, Ambler Gareth, Alberti Andrea, Yoshimura Sohei, Brown Martin M, Shiozawa Masayuki, Lip Gregory Y H, Venti Michele, Acciarresi Monica, Tanaka Kanta, Mosconi Maria Giulia, Takagi Masahito, Jäger Rolf, Muir Keith, Inoue Manabu, Schwab Stefan, Bonati Leo H, Lyrer Philippe A, Toyoda Kazunori, Caso Valeria, Werring David J, Kallmünzer Bernd, Engelter Stefan T, NOACISP-LONGTERM, Erlangen Registry, CROMIS-2, RAF, RAF-DOAC, SAMURAI-NVAF and Verona Registry Collaborators

Zitation

Polymeris A, Macha K, Paciaroni M, Wilson D, Koga M, Cappellari M, Schaedelin S, Zietz A, Peters N, Seiffge D, Haupenthal D, Gassmann L, De Marchis G, Wang R, Gensicke H, Stoll S, Thilemann S, Avramiotis N, Bonetti B, Tsivgoulis G, Ambler G, Alberti A, Yoshimura S, Brown M, Shiozawa M, Lip G, Venti M, Acciarresi M, Tanaka K, Mosconi M, Takagi M, Jäger R, Muir K, Inoue M, Schwab S, Bonati L, Lyrer P, Toyoda K, Caso V, Werring D, Kallmünzer B, Engelter S, NOACISP-LONGTERM, Erlangen Registry, CROMIS-2, RAF, RAF-DOAC, SAMURAI-NVAF and Verona Registry Collaborators. Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation. Ann Neurol 2021; 91:78-88.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Ann Neurol 2021; 91

Veröffentlichungsdatum

29.11.2021

eISSN (Online)

1531-8249

Seiten

78-88

Kurzbeschreibung/Zielsetzung

To investigate the safety and effectiveness of direct oral anticoagulants (DOAC) versus vitamin K antagonists (VKA) after recent stroke in patients with atrial fibrillation (AF) aged ≥85 years.